Cost effectiveness of peginterferon α-2b plus ribavirin versus interferon α-2b plus ribavirin for initial treatment of chronic hepatitis C
In: Gut, Vol. 52 (2003), No. 3, pp. 425 - 432
2003article/chapter in journal
EconomicsFaculty of Business Administration and Economics » Business Administration » Health Care Management
Related: 1 publication(s)
Title in English:
Cost effectiveness of peginterferon α-2b plus ribavirin versus interferon α-2b plus ribavirin for initial treatment of chronic hepatitis C
Author:
Wasem, JürgenUDE
- GND
- 110790677
- LSF ID
- 5214
- ORCID
- 0000-0001-9653-168X
- Other
- connected with university
- Other
- corresponding author
Contributor:
International Hepatitis Interventional Therapy (IHIT) Group
Year of publication:
2003
Language of text:
English